Detection of stones in the kidney through imaging is a predominant screening method and the foremost step in choosing the ideal treatment for kidney stone disease. The best first imaging modalities to employ to assess patients with suspected obstructive urolithiasis vary according to the recommendations offered by the American Urological Association (AUA), European Association of Urology (EAU) and American College of Radiology (ACR); the best definitive diagnosis is regularly made with non-contrast Computed Tomography of the abdomen and pelvis, however, doing so exposes individuals to ionizing radiation. Ultrasonography-derived compounds have less radiation than C.T. but have poorer specificity and accuracy. However, randomized controlled experiments comparing these imaging modalities revealed comparable diagnostic accuracy in the emergency unit. Each modality has benefits and drawbacks. Plain radiography of the kidney, ureter and bladder (KUB) is less beneficial in acute stones and perhaps most useful in assessing interval stone development in patients with established stone disease. Although MRI offers the prospect of 3D imaging without radioactive contamination, it is expensive, and at the moment, it is challenging to see stones. Future advancements are anticipated to improve all the imaging modalities for the diagnosis and management of stones in the kidney. Clinicians may benefit from a suggested approach for detecting patients with stone former in consideration of the recommended practices and a random control study.